Retirement Systems of Alabama Trims Stock Position in Humana Inc. (NYSE:HUM)

Retirement Systems of Alabama decreased its holdings in Humana Inc. (NYSE:HUM) by 1.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,201 shares of the insurance provider’s stock after selling 380 shares during the quarter. Retirement Systems of Alabama’s holdings in Humana were worth $8,299,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in HUM. Capital Advisors Ltd. LLC boosted its stake in shares of Humana by 17.0% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after acquiring an additional 31 shares during the last quarter. Moors & Cabot Inc. lifted its position in Humana by 2.5% during the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares in the last quarter. Harbour Investments Inc. grew its holdings in Humana by 10.5% during the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after purchasing an additional 41 shares during the period. OLD National Bancorp IN increased its position in Humana by 1.8% in the third quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock worth $828,000 after buying an additional 45 shares in the last quarter. Finally, Your Advocates Ltd. LLP raised its stake in shares of Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

Shares of NYSE:HUM opened at $233.89 on Wednesday. The firm has a fifty day simple moving average of $274.43 and a two-hundred day simple moving average of $322.89. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $475.00. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $28.16 billion, a P/E ratio of 20.72, a PEG ratio of 2.15 and a beta of 0.53.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. On average, analysts expect that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.51%. Humana’s payout ratio is presently 31.36%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. UBS Group reduced their target price on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 4th. Jefferies Financial Group cut shares of Humana from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Stephens reiterated an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Finally, Oppenheimer lowered their price objective on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $300.50.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.